Shu‐Hua Yang

Central China Normal University — China

Physics and Astronomy · Physical Sciences

11h-index324citations52works4.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulsars and Gravitational Waves Research(29), Stellar, planetary, and galactic studies(14), Cosmology and Gravitation Theories(12), High-pressure geophysics and materials(12), Geophysics and Gravity Measurements(9)

Publications52 total

Non-Newtonian Gravity Effects of Color-Flavor-Locked Strange Stars and the Second Component of the GW190814 Event
Chinese Astronomy and Astrophysics·2025
Spectroscopic orbit and variability of the Be star V1624 Cyg = 28 Cyg
Astronomy and Astrophysics·2025Open Access
Digital pesticide: a comprehensive pesticide information database with dynamic web platform for artificial intelligence applications
Pest Management Science·2025· 2 citedOpen Access
Strange stars admixed with mirror dark matter: Confronting observations of XTE J1814-338
Physical review. D/Physical review. D.·2025· 11 cited
Establishment and Validation of an Early Detection Model for Gastric Cardia Adenocarcinoma Based on Autoantibody Serological Characteristics
SSRN Electronic Journal·2025Open Access
Non-Newtonian gravity in color-flavor locked strange stars and the <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si16.svg" display="inline" id="d1e769"><mml:mrow><mml:mn>2</mml:mn><mml:mo>.</mml:mo><mml:mn>6</mml:mn><mml:mspace width="0.16667em"/><mml:msub><mml:mrow><mml:mi>M</mml:mi></mml:mrow><mml:mrow><mml:mo>⊙</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:math> component in GW190814
New Astronomy·2024· 1 cited
1437P Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PBO) + CT in HER2-negative advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJC): RATIONALE-305 study minimum 3-year survival follow-up
Annals of Oncology·2024· 5 cited
Color-flavor locked strange stars admixed with mirror dark matter and the observations of compact stars
Journal of Cosmology and Astroparticle Physics·2024· 10 cited
397MO Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PD-L1 biomarker analysis from RATIONALE-305
Annals of Oncology·2024· 9 citedOpen Access
139MO Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Final analysis results of the RATIONALE-305 study
Annals of Oncology·2023· 4 citedOpen Access
LBA80 Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Final analysis results of the RATIONALE-305 study
Annals of Oncology·2023· 16 cited
Neutron Star Phase Transition as the Origin for the Fast Radio Bursts and Soft Gamma-Ray Repeaters of SGR J1935 + 2154
The Astrophysical Journal·2023· 5 citedOpen Access
Deconfinement phase transition in neutron stars and astronomical tests
Zhongguo kexue. Wulixue Lixue Tianwenxue·2023Open Access
Confronting Strange Stars with Compact-Star Observations and New Physics
Universe·2023· 29 citedOpen Access
Strange stars confronting with the observations: <scp>Non‐Newtonian</scp> gravity effects, or the existence of a dark‐matter core
Astronomische Nachrichten·2022· 2 cited
Strange stars with a mirror-dark-matter core confronting with the observations of compact stars
Physical review. D/Physical review. D.·2021· 8 citedOpen Access
Non-Newtonian gravity in strange stars and constraints from the observations of compact stars
New Astronomy·2021· 7 cited
Strange stars with a mirror-dark-matter core confronting with the\n observations of compact stars
arXiv (Cornell University)·2021· 25 citedOpen Access
Constraints from compact star observations on non-Newtonian gravity in strange stars based on a density dependent quark mass model
Physical review. D/Physical review. D.·2021· 20 citedOpen Access
154P Investigation of PD-L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with VENTANA PD-L1 (SP263) assay and Combined Positive Score (CPS)
Annals of Oncology·2020· 9 cited
page 1 of 3Next →

Frequent Co-authors

Xiaoping Zheng(18), Chun‐Mei Pi(12), P. Harmanec(6), Miao Kang(5), Xuewen Liu(4), Jiarong Li(4), R-H. Xu(4), D-Y. Oh(4), Josep Tabernero(4), Marcia Cruz‐Correa(4), Yuxian Bai(4), Roberto Pazo-Cid(4), L. Li(4), Markus Moehler(4), G. A. H. Walker(4), Nana Pan(4), H. Ak(4), Fridolin Weber(3), Jingwen Shi(3), Kyung-Woo Lee(3)